Impact of Insurance Status on the Day of Admission and Clinical Outcome on Acute Myeloid Leukemia (AML)Patients

被引：0
|
作者：
Ahmad, Bilal [1 ]
Maymani, Hossein [1 ]
Saeed, Haseeb [1 ]
Khawandanah, Mohamad [1 ]
Srour, Samer A. [1 ]
Machiorlatti, Michael G. [2 ]
Asch, Adam S. [1 ]
Cherry, Mohamad [1 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[2] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Challenges in Converting Acute Myeloid Leukemia (AML) Genomics Into AML Clinical Trials
    Caywood, Emi H.
    Kolb, E. Anders
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (36) : 4238 - +
  • [42] Evaluation of Clinical, Hematological and Flow Cytometry Dates in Elderly Patients with Acute Myeloid Leukemia: Impact on Clinical Outcome
    Jardim Silva, Alessandra Suelen
    Silva Junior, Lenilton Silva D. A.
    de Medeiros Oliveira, Gustavo Henrique
    Martins Oliveira Eloi Silva, Antonia Eduarda
    Andrade Lima, Joao Pedro
    Soares, Victor Lima
    Freitas, Rodrigo Villar
    Bahia, Frank
    Oliveira, Taissa Moura
    Silva, Dany G. K. C.
    Sales, Valeria S. F.
    De Oliveira Paiva, Hugo Diogenes
    Araujo, Rafael Santiago
    Paiva, Aldair Sousa
    Cavalcanti, Geraldo Barroso, Jr.
    BLOOD, 2019, 134
  • [43] Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia
    Xu, Lu-Hong
    Wang, Yin
    Chen, Zhi-Yuan
    Fang, Jian-Pei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (04) : 1011 - 1020
  • [44] Clinical profile and outcome of patients of acute myeloid leukemia with high hyperdiploidy
    Sharma, Sanjeev Kumar
    Sharma, Monica
    Seth, Tulika
    Mishra, Pravas
    Chowdhry, Mohit
    Mahapatra, Manoranjan
    Saxena, Renu
    LEUKEMIA RESEARCH, 2012, 36 (03) : E60 - E61
  • [45] The Impact of Comorbidities and Organ Dysfunction Commonly Used for Clinical Trial Eligibility Criteria on Outcome in Acute Myeloid Leukemia (AML) Patients Receiving Induction Chemotherapy
    Statler, Abby
    Hobbs, Brian P.
    Radivoyevitch, Tomas
    Siebenaller, Caitlin
    Mukherjee, Sudipto
    Advani, Anjali S.
    Gerds, Aaron T.
    Nazha, Aziz
    Patel, Bhumika J.
    Carraway, Hetty E.
    Sekeres, Mikkael A.
    BLOOD, 2019, 134
  • [46] Prognostic Impact of Notch Signaling in Acute Myeloid Leukemia (AML)
    Kamga, Paul Takam
    Resci, Federica
    Dal Collo, Giada
    Adamo, Annalisa
    Bazzoni, Riccardo
    Mercuri, Angela
    Bonifacio, Massimiliano
    Krampera, Mauro
    BLOOD, 2018, 132
  • [47] Clinical and biological analysis of acute myeloid leukemia (AML)-cutis
    Kawamura, Machiko
    Yamaguchi, Tsukasa
    Kaneko, Yasuhiko
    Haruta, Masayuki
    Maseki, Nobuo
    Kobayashi, Hirofumi
    CANCER SCIENCE, 2021, 112 : 506 - 506
  • [48] Impact of Weekend Admissions on Quality of Care and Outcomes in Patients with Acute Myeloid Leukemia (AML).
    Bejanyan, Nelli
    Fu, Alex Z.
    Fu, Rao
    Kalaycio, Matt
    Advani, Anjali
    Sobecks, Ronald
    Copelan, Edward A.
    Sekeres, Mikkael A.
    BLOOD, 2008, 112 (11) : 678 - 678
  • [49] Clinical relevance of telomerase activity in acute myeloid leukemia (AML).
    Gruber, A
    Xu, DW
    Peterson, C
    Pisa, P
    BLOOD, 1997, 90 (10) : 304 - 304
  • [50] The amount of spontaneous apoptosis predicts outcome in acute myeloid leukemia (AML).
    Del Poeta, G
    Venditti, A
    Maurillo, L
    Buccisano, F
    Del Moro, B
    Suppo, G
    Epiceno, AM
    Cox, MC
    Masi, M
    Amadori, S
    BLOOD, 2000, 96 (11) : 543A - 543A
12345